Imprinted X chromosome inactivation at the gamete-to-embryo transition

Mol Cell. 2024 Apr 18;84(8):1442-1459.e7. doi: 10.1016/j.molcel.2024.02.013. Epub 2024 Mar 7.

Abstract

In mammals, dosage compensation involves two parallel processes: (1) X inactivation, which equalizes X chromosome dosage between males and females, and (2) X hyperactivation, which upregulates the active X for X-autosome balance. The field currently favors models whereby dosage compensation initiates "de novo" during mouse development. Here, we develop "So-Smart-seq" to revisit the question and interrogate a comprehensive transcriptome including noncoding genes and repeats in mice. Intriguingly, de novo silencing pertains only to a subset of Xp genes. Evolutionarily older genes and repetitive elements demonstrate constitutive Xp silencing, adopt distinct signatures, and do not require Xist to initiate silencing. We trace Xp silencing backward in developmental time to meiotic sex chromosome inactivation in the male germ line and observe that Xm hyperactivation is timed to Xp silencing on a gene-by-gene basis. Thus, during the gamete-to-embryo transition, older Xp genes are transmitted in a "pre-inactivated" state. These findings have implications for the evolution of imprinting.

Keywords: DNA methylation; H3K27me3; LINE; Polycomb; X hyperactivation; Xist; chromatin accessibility; imprinted X inactivation; mouse preimplantation embryo; zygotic genome activation.

MeSH terms

  • Animals
  • Embryo, Mammalian
  • Epigenesis, Genetic
  • Female
  • Genomic Imprinting
  • Germ Cells
  • Male
  • Mammals / genetics
  • Mice
  • RNA, Long Noncoding* / genetics
  • X Chromosome / genetics
  • X Chromosome Inactivation* / genetics

Substances

  • RNA, Long Noncoding